JC-virus seroconversion in multiple sclerosis patients receiving natalizumab

Abstract

Our data suggest that JCV reactivation occurs during NTZ therapy and leads to an increase in the anti-JCV antibodies titre, thus making them more easily detectable by the second-generation ELISA test.